Several trials reported adverse effects in the acyclovir arm such as rise in hepatic transaminases Serum glutamic oxaloacetic transaminase (SGOT) and Serum glutamic pyruvic transaminase (SGPT), rash, nephrotoxicity and delirium. Here, GPT is linked to delirium.